Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent

Details for Australian Patent Application No. 2005270336 (hide)

Owner Active Biotech AB

Inventors Wallen-Ohman, Marie; Hedlund, Gunnar; Forsberg, Goran

Agent Davies Collison Cave

Pub. Number AU-B-2005270336

PCT Pub. Number WO2006/015882

Priority 0402025-1 13.08.04 SE; 60/601,548 13.08.04 US

Filing date 12 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 24 November 2011

International Classifications

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015882 Priority application(s): WO2006/015882

24 November 2011 Application Accepted

  Published as AU-B-2005270336

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270341-Modulation of alkaloid biosynthesis in plants and plants having altered alkaloid biosynthesis

2005270334-Functional sugar replacement